HIM
RMTI icon

Hillsdale Investment Management’s Rockwell Medical RMTI Stock Holding History

Hillsdale Investment Management’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,080
Closed -$241K – 666
2024
Q3 		$241K Buy
+6,080
New +$164K 0.02% 389

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hillsdale Investment Management's RMTI Position: Q4 2024 in Review

Hillsdale Investment Management sold out of Rockwell Medical (RMTI) in Q4 2024, closing a stake of 6,080 shares — an estimated $241K sold.

Hillsdale Investment Management first reported a position in RMTI in Q3 2024 and held it in 1 quarter. The position peaked at $241K in Q3 2024. 53 funds tracked by Wall St. Rank hold RMTI as of Q4 2024.

  • Hillsdale Investment Management reported no remaining Rockwell Medical position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 6,080 Rockwell Medical shares in Q4 2024, an estimated $241K.
  • Hillsdale Investment Management first reported a position in Rockwell Medical in Q3 2024 and held it in 1 quarter.
  • Hillsdale Investment Management's Rockwell Medical position peaked at $241K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.